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In a bid to investigate the influence of menopausal on coronary heart disease, plasma creatine kinase (CK) and 
lactate dehydrogenase (LDH) enzymes were analysed on a prospective cohort of 100 women attending Irrua 
Specialist Teaching Hospital (ISTH), Irrua, Edo state-Nigeria. They were divided into two groups; postmenopausal 
women (n = 50) which serve as the test group and the premenopausal women (n = 50) which serves as the control 
group. The control group were aged 25-40 with a mean age of 34 years, while the postmenopausal women were 
aged 45 years and above with a mean age of 58 years. Information on menopausal status and other risk factors were 
obtained while venous blood samples were collected for the analysis of enzyme activities herein studied using 
standard laboratory procedures. Results which are presented as mean ± standard deviation showed significantly 
higher (P<0.05) CK and LDH activities in postmenopausal women (82.88 ± 23.63; 174.28 ± 76.63 respectivly) 
compared to those of premenopausal women (48.40±50.76; 126.44 ± 50.76 respectively). These findings therefore 
confirmed increase incidence of coronary heart diseases associated with menopause. 
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The word “menopause” [Greek word “Pausis” 
meaning ‘cessation’ and the root ‘men’ meaning 
‘monthly’] literally means the “end of monthly 
cycle”. Walker and Herndon (2008), describe it as 
change in human females where the end of fertility is 
traditionally indicated by the permanent stopping of 
monthly menstruation or menses. On the other hand, 
the term “perimenopause” which literally means 
“around the menopause”, refers to the menopause 
transition year, a span of time both before and after 
the date of the final episode of flow (Soules et al., 
2001). The menopause transition and postmenopause 
itself, is a natural life change, not a disease state or a 
disorder. The transition itself has a variable degre  of 
effects: it can be a difficult time of life for some 
women, less so for others. 
 
Although, menopause is perhaps most easily 
understood as the opposite process to menarche; the 
start of the monthly periods. According to Goff et al 
(2002), a woman has reached menopause when she 
has not had a menstrual period for 12 months in a 
row. However, menopause in women cannot 
satisfactorily be defined simply as the permanent 
“stopping of the monthly period” because in reality 
what is happening to the uterus is quite secondary to 
the process; it is what is happening to the ovaries that 
is the crucial factor. As an illustration of the central 
role of the ovaries, it is worth pointing out that when 
for medical reasons the uterus has to be surgically 
removed (hysterectomy) in a younger woman, her 
period will of course cease permanently, but as long 
as at least one of her ovaries is still functioning, the 
woman will not have reached menopause. Even 
without the presence of the uterus, ovulation and the 
release of the sequence of reproductive hormone will 
continue to cycle on, until menopause is reached. In 
contrast to this, in circumstances where a woman’s 
ovaries are removed (Oopherectomy), even if the 
uterus were to be left intact, the woman will 
immediately be in “surgical menopause”. Surgical 
menopause is a menopause which is induced both 
suddenly and totally by removal of both ovaries prior 
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to the natural menopause (Minkin et al., 1997; Kato 
et al., 1998). 
 
In younger women, during a normal menstrual cycle 
the ovaries produce estrogen, testosterone and 
progesterone in a cyclical pattern under the influece 
of follicle stimulating hormone (FSH) and luteinizing 
hormone (LH) which are both produced by the 
pituitary gland (Burger, 1994). However, the 
menopause is characterized by marked and often 
dramatic variation in FSH and estrogen (estradiol) 
level (Burger, 1994). Menopause is based on natural 
or surgical cessation of estradiol and progesterone 
production by the ovaries, which are part of the 
body’s endocrine system of hormone production 
(Simpson and Davis, 2001). Menopause can be 
classified based on the level of testosterone, estrogen 
and progesterone which plays a number of critical 
roles in a woman’s health during and after 
menopause. Based on this, twelve (12) types of 
menopause can be identified and are as described in 
the free encyclopedia (Wikipedia; accessed, 2011). 
 
The signs and effect of the menopause transition can 
begin as early as 35 or at mid to late 40s. The 
duration of perimenopause with noticeable bodily 
effects can be as brief as a few years during which 
many women undergo noticeable and clinically 
observable physical changes resulting from hormonal 
fluctuations such as “hot flash” or “hot flush” 
sensation (Freeman et al., 2007; Twiss et al., 2007). 
 
Studies have shown that after menopause, women 
experience an increase risk of heart disease, 
osteoporosis and bone fracture (Nelson et al., 1994; 
Simkin-silverman et al., 1995). Researchers have also 
connected this pattern to decreasing levels of the 
female hormone estrogen during menopause (Twiss 
et al., 2007). In this regards, estrogen has been 
reported to be associated with higher level of high-
density lipoprotein cholesterol (HDL-C) and lower-
density lipoprotein cholesterol (LDL-C) (Demissie et 
al., 2006). As such, Demissie et al., (2006), reported 
that withdrawal of the natural estrogen that occurs in 
menopause leads to lower HDL and higher LDL and 
thus increasing the risk of heart disease. Of interest is 
the activities of plasma creatine kinase (CK) and 
lactate dehydrogenase (LDH) enzymes which are 
known to be distributed in a variety of tissues and 
their serum levels elevated in a variety of clinical 
conditions such as myocardial infarction, haemolysis, 
and disorders of the liver, Kidney, lungs, brain 
damage and Muscle, which serves as markers for the 
state of tissue or organ (Schumann et al., 1998). 
 
The aim of the present study therefore is to 
investigate the influence of menses cessation 
(menopause) on markers of coronary heart diseases 
via assessing the level of plasma creatine kinase (CK)
and lactate dehydrogenase (LDH) enzymes activities. 
 
MATERIALS AND METHODS 
 
Study area: This cross-sectional study was carried 
out in Ekpoma, Esan West Local Government Area 
of Edo State. Ekpoma is a rural area located at 
latitude 6.750N and longitude 6.130E of the 
Greenwich Meridian with an estimated population 
size of 59,618 people (CSSR, 2008). 
 
Study population: The study population comprised a 
total of one hundred (100) women made up of fifty 
(50) apparently healthy postmenopausal women aged 
45 and above, and fifty (50) apparently healthy 
reproductive women between the ages of 25 and 40 
years as control group. Subjects were randomly 
recruited in the study area. 
 
Inclusion criteria : This includes apparently healthy 
postmenopausal women who are indigene of the 
study area. 
 
Exclusion criteria: Include pregnant women, 
smokers, athletic and adolescent females. 
 
Sample collection: After an informed consent was 
obtained from the subjects, five milliliters of blood 
samples were collected by venipuncture technique 
from subjects (both test and control) into lithium 
heparinized vacuum tubes, mixed gently and spun at 
1000 rpm for 10 minutes at room temperature to 
obtain plasma which was extracted into plain tubes 
and frozen at -4oC until required for further analysis. 
 
Sample analysis/assay: Determination of plasma 
Creatine kinase (CK) activity was carried out using 
the method described in the kit assay system 
(RANDOX United Kingdom) while plasma lactate 
dehydrogenase (LDH) activity was estimated by 
spectrophotometric method of Societal (1989) and 
Scientific Committee (1982) with kit assay system 
(BioSystem, Spain). 
 
Statistical analysis: The data obtained were analysed 
statistically, the Mean±standard deviation values 
were calculated in each case. The Students t- test 
statistical method was employed for comparison 
using SPSS software package version 16.0. A P-value 
(p≤0.05) was considered statistically significant at 
95% confidence level. 
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Table 1 shows the results obtained in the 
investigation in their SI unit (U/L) and reveals the 
mean ± standard deviation of plasma CK and LDH 
activities of postmenopausal women and control 
group as 82.88 ± 23.65; 48.40 ± 23.00 and 174.28 ± 
76.63; 126.44 ± 50.76 respectively.
 
 
Table 1: Comparison of creatine kinase (CK) and lactate dehydrogenase (LDH) activities in plasma of test 
and control subjects 
 
Parameters             Control (n=50)           Test (n=50)         t – value      p – value                   
 
CK (µ/L)                 48.40±23.00a             82.88±23.65b        7.39            < 0.05 
 
LDH (µ/L)              126.44±50.76a           174.28±76.63b       3.68            < 0.05 
   
Results are mean ± standard deviation; values in a row having different superscript are statistically different at 





The results of the present study showed that plasma 
CK and LDH activities in postmenopausal women 
were significantly elevated when compared to that of 
the control subjects (table 1). It has previously been 
reported that it is partly a lack of estrogen that 
increases a woman’s risk for developing various 
acute and chronic diseases such as myocardial 
infarction, coronary heart disease, Duchenne’s 
muscular dystrophy, stroke and endometrial cancer 
(Grady et al., 1992). Hence, the results of the present 
study agrees with several studies which reported that 
increase in plasma activities of these enzymes may be 
due to hormonal (estrogen) influence on the 
cardiovascular system, which play a vital role in lipid 
metabolism mediated by estrogen receptor alpha and 
Beta (ERα and ERβ) (Sweetin and Thomson, 1973; 
Gebara et al., 1995; Demissie et al., 2006). This is 
evident by the fact that at a younger age and 
independently of difference in life style, women are 
at lower risk for coronary heart diseases than men 
and that this disparity tends to disappear after 
menopause (Barrett-connor, 2003). On this evidence, 
the hypothesis as to the protective effect of estrogen 
against atherosclerosis has been based. 
 
Also in the report of Demissie t al. (2006), they 
found out that at the transcriptional level, estrogen 
increases hepatic expression of apoprotein gene and 
the low density lipoprotein (LDL) receptor and 
decrease the transcription of the lipoprotein lipase 
(LPL) gene through ERα. Thus, when estrogen level 
decrease after menopause, an increase in LPL activity 
is observed and this probably contributes to the 
increase free fatty acids (FFA) and accumulation of 
abdominal fat, a factor that causes increased risk for 
cardiovascular disease in postmenopausal women. 
On the other hand, Gebara et al. (1995) reported that 
estrogen is involved in proliferation of adipocytes, 
whereas their deprivation at menopause increases 
central obesity which is associated with a more 
atherogenic profile, plasminogen activator inhibitor-1 
(PAI-1), interleukin-6 (IL-6) CRP level, insulin 
resistance and several other components of the 
metabolic disorders, all of which contributes to the 
increased incidence of cardiovascular morbidity in 
postmenopausal women and hence increase serum 
activities of these enzymes which can serve as 
markers for cardiac disease. By implication, the 
results of the present study are further justified. 
 
In the study conducted by Mendelsohn and Karas, 
(1999), it was observed that; estrogen possesses 
vasodilating effect in premenopausal women by 
mediating increased  production of vasodilating 
molecules such as nitric oxide (NO) and 
prostracyline, as well as decreasing vasoconstricting 
factors such as edothelin-1. The NO in these 
premenopausal women attenuates the atherogenic 
process by decreasing the proliferation of vascular 
muscle cell. It also plays a central role in the 
production of cytokines, and decreases adhesion and 
accumulation of monocytes and platelets on the walls 
of the affected vessels, thus decreasing 
cardiovascular disease risk in premenopausal women 
and hence reduced plasma CK and LDH activities 
(Mendelsohn and Karas, 1999). 
 
Jialal et al., (2004) found that in postmenopausal 
women where estrogen is absent or highly deficient, 
there is increased production of reactive oxygen 
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species (ROS), which participate in the oxidation of 
LDL molecules resulting in the formation of foam 
cells on the vessel walls, production of 
proinflammatory cytokines (TNFα and IL-6) and 
increased NO catabolism, thus leading to 
atherosclerotic lesion in postmenopausal women. The 
loss of antioxidant activity of estrogen in 
postmenopausal women could also increase 
vulnerability to muscle damage (Cardiac and 
Skeletal) (Barrett- Connor and Bush, 1991; Davis et 
al., 1994; Liu et al., 2001) and hence increased serum 
activities of these enzymes here in study. Stamler et 
al. (1978) also reported that obesity, which is also 
observed in postmenopausal women were seen as 
indirect coronary risk due to its involvement in 
elevated blood pressure (hypertension) and 
hypercholesterolaemia leading to an increased risk of 
ischaemic heart disease in postmenopausal women. 
From the results of this work, significant differenc s 
of plasma activities of creatine kinase (CK) and 
lactate dehydrogenase (LDH) were observed in 
postmenopausal women compared to premenopausal 
women. Conclusively, menopause can be said to be 
associated with a constellation of physical changes, 
some of which are directly attributed to the loss of 
estrogen, and hence, increased incidence of 
cardiovascular diseases (which is the largest healt 
threat to women after menopause). It is important to 
stress however, that there are a variety of treatments 
available to protect postmenopausal women from 
developing serious health problems and most 
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